+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immunological studies with group B arthropod-borne viruses. V. Evaluation of cross-immunity against type 1 dengue fever in human subjects convalescent from subclinical natural Japanese encephalitis virus infection and vaccinated with 17D strain yellow fever vaccine



Immunological studies with group B arthropod-borne viruses. V. Evaluation of cross-immunity against type 1 dengue fever in human subjects convalescent from subclinical natural Japanese encephalitis virus infection and vaccinated with 17D strain yellow fever vaccine



American Journal of Tropical Medicine and Hygiene 15(4): 588-600




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 043340202

Download citation: RISBibTeXText

PMID: 4287392


Related references

Immunological studies of group B arthropod-borne virus. V. Evaluation of cross-immunity against type 1 dengue fever in human subjects convalescent from sub clinical natural Japanese encephalitis virus infection and vaccinated with 17D strain yellow fever vaccine. Amer J Trop Med Hyg 15(4): 588-600, 1966

Immunological studies with group B arthropod-borne viruses, II. Effect of prior infection with Japanese encephalitis virus on the viremia in human subjects following administration of 17D yellow fever vaccine. Amer Jour Trop Med And Hyg 11(4): 562-569, 1962

Immunological studies with group B arthropod-borne viruses. I. Broadened neutralizing antibody spectrum induced by strain 17D yellow fever vaccine in human subjects previously infected with Japanese encephalitis virus. American Journal of Tropical Medicine and Hygiene 11: 550-561, 1962

Immunological studies with group B arthropod-borne viruses. III. Response of human subjects to revaccination with 17D strain yellow fever vaccine. American Journal of Tropical Medicine and Hygiene 11: 570-575, 1962

Immunological studies with Group B arthropod-borne viruses. IV. Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine. Amer Jour Trop Med And Hyg 12(2): 230-235, 1962

Immunological studies with group B arthropod-borne viruses. IV. Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine. American Journal of Tropical Medicine and Hygiene 12: 230-235, 1963

Immunological studies with group B arthropod-borne viruses. VI. Hemagglutination-inhibiting antibody responses to 17D yellow fever vaccine in human subjects with different degrees of complexity of pre-vaccination group B virus experience. American Journal of Tropical Medicine and Hygiene 15(4): 601-610, 1966

Epidemics of mosquito borne virus diseases in the pacific area exclusive of dengue and chikungunya viruses with emphasis on the past 5 years human japanese encephalitis murray valley encephalitis venezuelan encephalitis western encephalitis st louis encephalitis ross river virus yellow fever virus. Japanese Journal of Medical Science & Biology 20(SUPP): 7-10, 1967

Immunity in group B arthropod-borne virus diseases; accidental dengue I virus infection in a laboratory worker with antibodies to Japanese encephalitis virus. American Journal of Hygiene 69(1): 60-67, 1959

Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes. Human Vaccines 2(2): 60-67, 2006

West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses. Vector Borne and Zoonotic Diseases 5(2): 137-145, 2005

Infection of graces antheraea eucalypti cells with arboviruses japanese encephalitis virus yellow fever virus st louis encephalitis virus cache valley virus bunyamera virus tahyna virus snowshoe hare virus california group viruses indiana vesicular stomatitis virus. American Journal of Tropical Medicine & Hygiene 17(6): 889-893, 1968

Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax-Den2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All. Human Vaccines 2(2): 60-67, 2006

Broad neutralization of wild-type dengue virus isolates following immunization in monkeys with a tetravalent dengue vaccine based on chimeric yellow fever 17D/dengue viruses. Virology 429(2): 91-98, 2012

Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: Biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model. Journal of Virology 77(6): 3655-3668, 2003